Status:
UNKNOWN
Gene Expression, Immunological Status and Metabolome in Glioma Patients
Lead Sponsor:
National Institute of Biology, Slovenia
Collaborating Sponsors:
Blood Transfusion Centre of Slovenia
University Medical Centre Ljubljana
Conditions:
Glioma
Eligibility:
All Genders
20-80 years
Brief Summary
Study on glioma patients treated with brain surgery is focusing on the analysis of their transcriptome expression profile measured in two immune cell populations, CD4+ T cells and CD56+ NK cells. The ...
Eligibility Criteria
Inclusion
- malignant glioma = glioblastoma (WHO IV) patients
Exclusion
- pregnancy
- metastases
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01525459
Start Date
December 1 2010
End Date
December 1 2012
Last Update
February 7 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Blood Transfusion Centre of Slovenia
Ljubljana, Slovenia, 1000
2
Department of Neurosurgery, University Medical Centre Ljubljana
Ljubljana, Slovenia, 1000
3
National Institute of Biology
Ljubljana, Slovenia, 1000